Navigation Links
Placental Protein Leads To The Onset Of Preeclampsia - Researcher Finds

A new study by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with a research team from The Hospital for Sick Children, Toronto, has confirmed //the previous findings that elevated levels of the sFlt1 placental protein leads to the onset of preeclampsia and also a second protein which, in combination with sFlt1, puts preeclampsic patient to a severe condition.

These new findings, reported in the June 4, 2006 on-line issue of Nature Medicine, provide another critical piece of information about this puzzling disease, which complicates five percent of all pregnancies worldwide and is a major cause of maternal and fetal mortality, particularly in developing nations.

‘Preeclampsia typically develops in the third trimester of pregnancy and is characterized by high blood pressure, edema and protein in the urine,’ explains the study’s senior author S. Ananth Karumanchi, MD, a nephrologist in the cat BIDMC and Assistant Professor of Medicine, Obstetrics and Gynecology at Harvard Medical School.

Three years ago, Karumanchi and his colleagues demonstrated that the placenta plays a central role in the course of these events, and that elevated levels of a placental protein called sFlt1 (soluble fms-like tyrosine kinase) are key to the onset of the disease.

However, for unknown reasons, a subset of preeclampsia patients will go on to experience severe preeclampsia – a group of dramatically escalated symptoms characterized by a sudden, massive rise in blood pressure, which can lead to the onset of seizures, as well as the development of fetal growth restriction and the HELLP syndrome. HELLP, which stands for hemolysis, elevated liver enzymes and low platelets, indicates that the mother’s liver and blood-clotting systems are not functioning properly, and the health of both mother and infant are in serious danger.

‘During the course of our previous experiments [to confirm the role of sFlt1 in the diseas
'"/>




Page: 1 2 3

Related medicine news :

1. Placental Proteins Could Be Responsible For Pre-eclampsia
2. Pregnant Women With Placental Infection Have Doubled Risk of Recurrence
3. Placental Problems in Women Linked With Caesarean Section
4. Lean Protein Could Be Key to Obesity Drugs
5. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
6. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
7. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
8. Protein in urine foresees heart disease
9. Levels Of Blood Proteins May Help Heart Disease Care
10. Protein signals need for heart surgery
11. Protein and fat improve memory
Post Your Comments:
(Date:12/2/2008)...rgoed for Tuesday, December 2, 2008 at 3 pm CST)--...Medical University of South Carolina in Charleston... of cancer from exposure to radiation during compu... overstated and that new estimates are several tim...he MUSC researchers presented their findings at th...
(Date:12/2/2008)...ec. 2 United American He...s and provides comprehensive healthcare,managemen...ssee, today,announced that its Board of Directors...zing the Company to repurchase up to $1.0 million ...gram allows for the Company,s common shares to be ...
(Date:12/2/2008)...ec. 2 Today a group of...ns, elected officials and other community leaders ... in Detroit/Wayne County to solidify participants,...e and economic successes and challenges play a rol...of the opening session of a three-day discussion t...
(Date:12/2/2008)... The Health Story Project was annou...ormerly known as “Clinical Document Architec...DA4CDT will continue as the label for the technica... to Health Level Seven (HL7) for ballot. The new n...ire EON) December 2, 2008 -- "Our group has ...
Breaking Medicine News(10 mins):Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5
...sleep deprived people should never get behind the ...can hamper the coordination of horizontal eye mov...he study was conducted on a group of 6 participant...Metropolitan University, who asked the volunteers ...
...a could be releasing dangerous levels of radioacti...'s standard for allowable levels of tritium are 10... higher than Europe. As a precautionary measure t...en under the age of 4 and pregnant women shouldn't...
...rs over the slight incisions on his patient's back...g vacuum , the thick dark blood slowly oozed out o...syrians, the Chinese and the ancient Egyptians all...t the corrupt blood," said Hajam as he deftly drai...
...a computerized garment that they say can help doct...on and schizophrenia . The high-tech garment is pa...g rate, blood pressure, skin temperature, body mov...orted online edition of the Daily Mail. It was i...
Other Medicine News:Health News:Tritium Risks at New Heights 2Health News:Ancient Healing Technique Gains New Popularity in Iraq 2Health News:Researchers Have Developed Computerized Garment to Diagnose Mental Illness 2
(Date:12/1/2008).../ -- Vical Incorporated (Nasdaq: VICL ) announce...yment from Merck & Co., Inc. based on Merck,s ...an investigational plasmid DNA (pDNA) cancer vacci...gene delivery technology and encodes human telomer...bject of separate license agreement. , , "T...
(Date:11/27/2008)...ymphoblastic leukemia relapse cases arise from a c... , MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNewswi...Hospital have identified distinctive genetic chang...hoblastic leukemia (ALL) that cause relapse. The f...r ALL relapse in children and, ultimately, in adul...
(Date:11/25/2008)...Newswire/ -- Kleinert Kutz and University of Loui...d transplant on Messina, New York resident, Jan "E...d Care Center on Monday, November 24. The innovat...shortly after 9 p.m. in a record nine hours. , ...h/20081125/DC48555-a ) , (Photo: http://www.n...
(Date:11/25/2008)... to Assess Survival of Patients Receiving Litx ver...patocellular Carcinoma , , BELLEVUE, Wash.,...Inc. (LSO) today announced the completion of enrol...Infusion Therapy(TM) (Litx(TM)) as a treatment for... known as hepatoma or primary liver cancer. , ...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 1Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2062 4Clot Busting Treatment Improves Bleeding Stroke Outcomes 19289 1Clot Busting Treatment Improves Bleeding Stroke Outcomes 19289 2Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 1Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 2Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 3Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 4Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 19286 5FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 1FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 2FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 3FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 4FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 5FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 6FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 7FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 8FDA Approves AstraZenecas Seroquel 28R 29 for Maintenance Treatment in Bipolar Disorder 19283 9
...N, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarmi...of CANCER (a peer-reviewed,journal of the American...taking the standard five-year regimen of the hormo...continue therapy early.(1), According to the autho...or issue that may negatively affect treatment effi...
...LPHIA, March 15, 2007-- The cause of one notorious...reat the ongoing,threat of another childhood disea... Research, researchers from Stony Brook University...orm of poliovirus,is effective in obliterating neu...been previously vaccinated against the virus. , By...
Other Medicine Technology:One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl
...t is a clinical chemistry assay that detects Ische...obalt binding capacity of albumin in a patient ser...A is produced when circulating albumin comes in co...chemia, the N-terminus of albumin is altered throu...
Medicine Products: